Dexamethasone in bronchiolitis: a randomised controlled trial

Area of Science:

• Pediatrics
• Respiratory Medicine
• Clinical Pharmacology

Background:

• Corticosteroids, including dexamethasone, are frequently used for infant bronchiolitis despite a lack of evidence for their efficacy.
• Bronchiolitis is a common respiratory infection in infants, often requiring hospitalization.

Purpose of the Study:

• To evaluate the effectiveness of dexamethasone in hospitalized infants diagnosed with bronchiolitis.
• To determine if dexamethasone impacts symptom resolution time and the need for oxygen therapy.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted involving infants under 12 months hospitalized for bronchiolitis.
• Participants received either intramuscular dexamethasone or a placebo for three doses.
• Key outcomes measured included time to symptom resolution and duration of oxygen therapy, assessed using clinical severity scores and pulse oximetry.

Main Results:

• No significant differences were observed between the dexamethasone and placebo groups in terms of symptom resolution time or duration of oxygen therapy.
• While more infants in the dexamethasone group initially had oxygen saturation below 95%, this did not translate to improved clinical outcomes.
• Demographics, illness duration, and viral status (RSV) did not alter the study's findings.

Conclusions:

• The study provides no support for the use of dexamethasone in treating infants hospitalized with bronchiolitis.
• Current clinical practice of prescribing corticosteroids for bronchiolitis may not be evidence-based.